Simple Yes, Precise No
Newest Gene Editing Method Not Yet Ready for Prime Time
By Anette Breindl
Friday, June 28, 2013
Genome editing the ability to change a DNA sequence at a specific site in the genome could be useful for improving the scientific understanding, and ultimately the treatment, of a multitude of diseases. But scientists reported last week that what is currently the simplest technology for gene editing, CRISPR, is not always precise as would be necessary either for therapeutic applications, or for unambiguous scientific data.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.